Timothy Sanders - Ventas Senior Investment Officer
| VTR Stock | USD 68.28 0.52 0.77% |
Executive
Mr. Timothy Sanders is Senior Investment Officer of Ventas Inc. Sanders will join Ventas investment professionals to cultivate and enhance relationships with healthcare and senior housing operators and make value enhancing investments. He joined the Company from Capital Lending and Mortgage Group LLC an affiliate of Capital Funding Group a Baltimorebased mortgage banker that specializes in seniors housing and skilled nursing debt. He will be a member of the Ventas Senior Leadership Team. since 2015.
| Tenure | 10 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Ventas Management Efficiency
The company has Return on Asset of 0.018 % which means that on every $100 spent on assets, it made $0.018 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/26/2025, Return On Tangible Assets is likely to drop to 0. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ava Liasbooker | Healthpeak Properties | 60 | |
| Daniel JD | Healthpeak Properties | 59 | |
| Thomas Klaritch | Healthpeak Properties | 67 | |
| Tracy Porter | Healthpeak Properties | N/A | |
| Ankit Patadia | Healthpeak Properties | 46 | |
| Peter Scott | Healthpeak Properties | 44 | |
| Robert McCadden | Universal Health Realty | 62 | |
| Vikas Gupta | Omega Healthcare Investors | 43 | |
| Scott Bohn | Healthpeak Properties | 45 | |
| Adam Mabry | Healthpeak Properties | 39 | |
| Revell Michael | Healthcare Realty Trust | N/A | |
| Matthew CPA | Omega Healthcare Investors | 49 | |
| Austen Helfrich | Healthcare Realty Trust | 38 | |
| James Croy | Healthpeak Properties | N/A | |
| Peter Nyland | Sabra Healthcare REIT | N/A | |
| Megan Krull | Omega Healthcare Investors | 47 | |
| Gayle Capozzalo | Universal Health Realty | 70 | |
| Michael Sotelo | CareTrust REIT | N/A | |
| Susan Sidwell | National Health Investors | N/A | |
| Lauren Beale | CareTrust REIT | N/A | |
| Gail JD | Omega Healthcare Investors | 50 | |
Management Performance
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Justin Hutchens, Executive Officer | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 42.46 B | ||||
| Shares Outstanding | 437.14 M | ||||
| Shares Owned By Insiders | 0.60 % | ||||
| Shares Owned By Institutions | 99.67 % | ||||
| Number Of Shares Shorted | 12.13 M | ||||
| Price To Earning | 909.80 X |
Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.